State Street’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.7M | Sell |
1,259,258
-54,492
| -4% | -$2.37M | ﹤0.01% | 1632 |
|
|
2025
Q1 | $49.1M | Sell |
1,313,750
-153,364
| -10% | -$5.73M | ﹤0.01% | 1645 |
|
|
2024
Q4 | $66.5M | Buy |
1,467,114
+55,475
| +4% | +$2.51M | ﹤0.01% | 1577 |
|
|
2024
Q3 | $82.9M | Sell |
1,411,639
-149,723
| -10% | -$8.79M | ﹤0.01% | 1435 |
|
|
2024
Q2 | $61.4M | Buy |
1,561,362
+213,565
| +16% | +$8.4M | ﹤0.01% | 1554 |
|
|
2024
Q1 | $89.6M | Buy |
1,347,797
+968,527
| +255% | +$64.4M | ﹤0.01% | 1379 |
|
|
2023
Q4 | $10.6M | Buy |
379,270
+175,753
| +86% | +$4.91M | ﹤0.01% | 2557 |
|
|
2023
Q3 | $4.33M | Buy |
+203,517
| New | +$4.33M | ﹤0.01% | 2987 |
|